MicroCal was founded in 1977 with the mission to develop, manufacture and market ultrasensitive calorimeters. Prior to the formation of MicroCal, commercial calorimeters were extremely difficult to use, had long experimental times and required large amounts of sample due to poor sensitivity. As a result, the use of microcalorimetry was limited almost exclusively to specialists who devoted themselves primarily to calorimetry. Over the past thirty years, MicroCal has been privileged to participate in the development and advancement of an important technology that has found broad application in the basic research of biomolecules and the discovery and development of many new therapeutics and biotherapeutics. There are over 7,900 peer reviewed publications that include data collected on MicroCal products. Mass Capital provided MicroCal with mezzanine capital that was used to support a recapitalization led by Riverside Partners.
Visit Website: www.microcal.com